Safety and effectiveness of renoportal bypass in patients with complete portal vein thrombosis: An analysis of 10 patients

Cristiano Quintini, Mario Spaggiari, Koji Hashimoto, Federico Aucejo, Teresa Diago, Masato Fujiki, Charles Winans, Giuseppe D'Amico, Loris Trenti, Dympna Kelly, Bijan Eghtesad, Charles Miller – 25 November 2014 – The presence of portal vein thrombosis (PVT) is still considered by many transplantation centers to be an absolute contraindication to liver transplantation because of the technical difficulties that it can present and its association with a higher rate of patient morbidity and mortality. Renoportal bypass (RPB) can help to remove these barriers.

Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation

Florence Wong, Wesley Leung, Mohammed Al Beshir, Max Marquez, Eberhard L. Renner – 25 November 2014 – Hepatorenal syndrome type 1 (HRS1) is acute renal failure in the setting of advanced cirrhosis, and it results from hemodynamic derangements, which should be fully reversible after liver transplantation. However, the rate of hepatorenal syndrome (HRS) reversal and factors predicting renal outcomes after transplantation have not been fully elucidated. The aim of this study was to assess outcomes of HRS1 patients after liver transplantation and factors predicting HRS reversal.

Subscribe to